BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
195 results:

  • 1. Detection of HER2 expression using
    Zhao L; Xing Y; Liu C; Ma S; Huang W; Cheng Z; Zhao J
    Breast Cancer Res; 2024 Mar; 26(1):40. PubMed ID: 38459598
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bony lesion analysis in carcinoma prostate: methylene diphosphonate bone scan vs. Gallium-68 psma-11 pet/ct.
    Ali H; Rashid Ul Amin S; Hai A; Nizar N
    J Ayub Med Coll Abbottabad; 2023; 35(3):415-418. PubMed ID: 38404083
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan.
    Akakura K; Uemura H; Kawakami S; Yokomizo A; Nakamura M; Nishimura K; Komori T; Ledesma DA
    Future Oncol; 2024 Apr; 20(12):781-798. PubMed ID: 38275149
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pharmacokinetic Parameters of Recombinant Human Cyclophilin A in Mice.
    Kalinina A; Grigorieva E; Smirnova A; Kazansky D; Khromykh L
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):57-69. PubMed ID: 38040985
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in Prostate cancer Patients After Definitive treatment With PSA Level ≤0.2 ng/mL.
    Lu Y; Wilson ZJ; Xu G; Xu Z; Pan T; Wei P
    Clin Nucl Med; 2023 Dec; 48(12):1021-1027. PubMed ID: 37801580
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of parametric imaging and SUV imaging with [
    Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Zhou Y; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):568-580. PubMed ID: 37792025
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Quantitative uptake in 99m Tc-EDDA/HYNIC-TOC somatostatin receptor imaging - the effect of long-acting release somatostatin analogue therapy.
    Gemmell AJ; Brown CM; Ray S; Small A
    Nucl Med Commun; 2023 Nov; 44(11):944-952. PubMed ID: 37578312
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Preclinical evaluation and pilot clinical study of [
    Ma X; Zhou X; Hu B; Li X; Yao M; Li L; Qin X; Li D; Yao Y; Hou X; Liu S; Chen Y; Wang Z; Zhou W; Li N; Zhu H; Jia B; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3838-3850. PubMed ID: 37555904
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of Baseline
    Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
    J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [
    Metser U; Kulanthaivelu R; Salawu A; Razak A; Mak V; Li X; Langer DL; MacCrostie P; Singnurkar A
    J Nucl Med; 2023 Sep; 64(9):1371-1377. PubMed ID: 37414444
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. 68 Ga-FAPI-04 PET/CT in Selected Breast cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.
    Alçın G; Arslan E; Aksoy T; Cin M; Erol Fenercioğlu Ö; Beyhan E; Ergül N; Çermik TF
    Clin Nucl Med; 2023 Sep; 48(9):e420-e430. PubMed ID: 37351868
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Enzalutamide Reduces Oxycodone Exposure in Men with Prostate cancer.
    Detert Oude Weme SEH; Hulskotte LMG; Vervenne WL; Imholz ALT; Cremers RGHM; Taxis K; Reyners AKL; van Berlo-van de Laar IRF; Jansman FGA; Benoist GE
    Clin Pharmacokinet; 2023 Jul; 62(7):989-996. PubMed ID: 37162620
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effectiveness of CT-image guidance in proton therapy for liver cancer and the importance of daily dose monitoring for tumors and organs at risk.
    Maeda Y; Kobashi K; Sato Y; Tamamura H; Yamamoto K; Matsushita K; Sasaki M; Tatebe H; Asahi T; Matsumoto S; Takamatsu S; Miyazaki K; Fujimoto R; Uchinami Y; Katoh N; Aoyama H
    Med Phys; 2023 Jun; 50(6):3274-3288. PubMed ID: 37099416
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The prognostic value of [
    Sachpekidis C; Weru V; Kopp-Schneider A; Hassel JC; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2699-2714. PubMed ID: 37099131
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.
    Penack O; Peczynski C; Koenecke C; Polge E; Kuhnl A; Fegueux N; Daskalakis M; Kröger N; Dreger P; Besley C; Schanz U; Bloor A; Ganser A; Forcade E; Corral LL; Passweg JR; Novak U; Moiseev I; Schoemans H; Basak GW; Chabannon C; Sureda A; Averbuch D; Glass B; de la Camara R; Peric Z
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072350
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
    Averbuch D; de la Camara R; Tridello G; Knelange NS; Bykova TA; Ifversen M; Dobsinska V; Ayas M; Hamidieh AA; Pichler H; Perez-Martinez A; Cesaro S; Sundin M; Badell I; Bader P; Johansson JE; Mirci-Danicar O; Sedlacek P; Paillard C; Gibson B; Lawson S; Kroeger N; Corbacioglu S; Mikulska M; Piñana JL; Styczynski J; Ljungman P
    Bone Marrow Transplant; 2023 May; 58(5):558-566. PubMed ID: 36849806
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Efficacy and Safety of
    Maric I; Weber M; Prochnow A; Schmitz J; Unger N; Schaarschmidt BM; Poeppel TD; Rischpler C; Bockisch A; Herrmann K; Jentzen W; Fendler WP
    J Nucl Med; 2023 Jun; 64(6):885-891. PubMed ID: 36732054
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting Intratibial Osteosarcoma Using Water-Soluble Copolymers Conjugated to Collagen Hybridizing Peptides.
    Subrahmanyam N; Yathavan B; Yu SM; Ghandehari H
    Mol Pharm; 2023 Mar; 20(3):1670-1680. PubMed ID: 36724294
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and treatment response assessment of primary bone lymphoma.
    Pu Y; Wang C; Xie R; Zhao S; Li K; Yang C; Li J; Xiang A; Wang Y; Chen L; Sun H
    Nucl Med Commun; 2023 Apr; 44(4):318-329. PubMed ID: 36722755
    [TBL] [Abstract] [Full Text] [Related]  

  • 20.
    Liu Y; Zhang C; Xu K; Wu K; Han X; Jiao D
    Clin Transl Oncol; 2023 May; 25(5):1297-1306. PubMed ID: 36472748
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.